Showing results (3121-3130 of 4,140) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|December 31, 1997
Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapyY Ono, K Ikeda, M X Wei, et al.Human Gene Therapy|December 31, 1997
Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transferY Saeki, N Matsumoto, Y Nakano, et al.Human Gene Therapy|February 4, 1998
Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individualsA Gervaix, L Schwarz, P Law, et al.Human Gene Therapy|April 3, 1998
Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cellsK Miyake, N Suzuki, H Matsuoka, et al.Human Gene Therapy|April 3, 1998
Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectorsW C Manning, S Zhou, M P Bland, et al.Human Gene Therapy|April 3, 1998
Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrinsC Qiu, M B De Young, A Finn, et al.Human Gene Therapy|April 3, 1998
Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliteransA Boehler, D Chamberlain, Z Xing, et al.Human Gene Therapy|April 3, 1998
Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vectorS L Hart, C V Arancibia-Cárcamo, M A Wolfert, et al.Human Gene Therapy|March 21, 1998
Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type IK Overturf, M Al-Dhalimy, K Manning, et al.Human Gene Therapy|March 21, 1998
Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexesL G Barron, K B Meyer, F C SzokaPageof 414